Placental lactogen (PL) is a hormone produced by the placenta during pregnancy. It plays a crucial role in regulating the metabolic state of the mother to support fetal growth and development. Ovine placental lactogen (oPL) is the specific form of this hormone found in sheep. Recombinant ovine placental lactogen (roPL) refers to the artificially synthesized version of this hormone, produced using recombinant DNA technology.
Ovine placental lactogen is a member of the prolactin/growth hormone family. It shares structural similarities with both prolactin (PRL) and growth hormone (GH), allowing it to bind to their respective receptors and exert similar biological effects . The primary function of oPL is to modulate maternal metabolism to ensure an adequate supply of nutrients to the developing fetus. It also plays a role in mammary gland development and lactation.
The production of recombinant ovine placental lactogen involves the insertion of the oPL gene into a suitable expression system, such as bacteria or mammalian cells. This allows for the large-scale production of the hormone in a controlled environment. The recombinant hormone is then purified and characterized to ensure it retains its biological activity .
Recombinant ovine placental lactogen has several applications in research and agriculture. In research, it is used to study the physiological roles of placental lactogen and its interactions with other hormones. In agriculture, roPL can be used to enhance reproductive performance and milk production in livestock.